MedPath

A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

Not Applicable
Recruiting
Conditions
Peripheral Artery Disease
Interventions
Device: Drug eluting Balloon
Registration Number
NCT05415995
Lead Sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Brief Summary

This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.

Detailed Description

This trail is conducted in several centers all around China. 202 subjects with below the knee arterial stenosis or occlusion will be recruited and randomized, this trail compares the efficacy and safety of Drug-coated Balloon (Zylox-Tonbridge) with a similar balloon catheter producted by Acotec. The subjects will be followed up when discharged /in 30 days/ 6 months.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
202
Inclusion Criteria
  • Age 18-85 years;
  • ≥70% diameter stenosis or occlusion in the target below-the-knee lesion;
  • Rutherford Category 3-6;
  • Subjects are willing to sign informed consent;
Exclusion Criteria
  • Planned major limb amputation within 30 days after the procedure;
  • In-stent stenosis in the target lesion;
  • Severely calcified target lesions;
  • Creatinine>2.5mg/dL;
  • History of allergies to anesthetics, contrast agents;
  • Subjects who have participated in any other drug or medical device clinical investigations and haven't reach the primary endpoint;
  • Other circumstances judged by researchers that are not suitable for enrollment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
101 Patients with Below The Knee Artery stenosis or occlusion in Experimental GroupDrug eluting BalloonPatients in this group use Drug eluting Balloon (Zylox-tonbridge), this is the product to be test in this clinical trail. The drug we coated is paclitaxel.
101 Patients with Below The Knee Artery stenosis or occlusion in Controlled GroupDrug eluting BalloonPatients in this group use Drug eluting Balloon(Acotec), this is a product that has got approved by NMPA in 2016.
Primary Outcome Measures
NameTimeMethod
Rate of primary patency of the target lesion180 days

Primary patency is defined as no target lesion occlusion, no clinical symptom driven target lesion revascularization and major limb amputation.

Secondary Outcome Measures
NameTimeMethod
Success rate of the techniqueImmediately after the intervention

On the basis of device success,technique success rate is defined as restored blood flow in the lesion after the treatment, and the residual stenosis ≤30%.

Success rate of the operationWithin 7 days

On the basis of technique success, operation success is defined as no adverse event happening.

Success rate of the deviceIntraoperation

Success rate of the device is defined as a situation that the balloon catheter reached the lesion site, dilated successfully without rupture, and was successfully withdrawn.

Trial Locations

Locations (20)

The First Hospital of Hebei Medical University

🇨🇳

Shijiazhuang, Hebei, China

The First Affiliated Hospital Of Dalian Medical University

🇨🇳

Dalian, Liaoning, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, Tianjin, China

The second hospital of Anhui Medical university

🇨🇳

Hefei, Anhui, China

Zhongshan Hospital Xiamen University

🇨🇳

Xiamen, Fujian, China

Hebei General Hospital

🇨🇳

Shijiazhuang, Hebei, China

HeNan Province People's Hospital

🇨🇳

Zhengzhou, Henan, China

The First Affiliated Hospital Of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

The central hospital of Wuhan

🇨🇳

Wuhan, Hubei, China

Nanjing Drum Tower Hospital, the affiliated hospital of Nanjing University medical school

🇨🇳

Nanjing, Jiangsu, China

The affiliated Hospital of QingDao University

🇨🇳

Qingdao, Shandong, China

Shanxi Bethune Hospital

🇨🇳

Taiyuan, Shanxi, China

General Hospital of Northern Theater Command

🇨🇳

Shenyang, Liaoning, China

The affiliated hospital of southwest medical university

🇨🇳

Luzhou, Sichuan, China

Affiliated HangZhou First People's Hospital, Zhejiang University School of medicine

🇨🇳

Hangzhou, Zhejiang, China

China-Japan Friendship Hospital

🇨🇳

Beijing, China

Huamei hospital, University of Chinese academy of sciences

🇨🇳

Ningbo, Zhejiang, China

Changhai Hospital

🇨🇳

Shanghai, China

Shanghai Ninth People's Hostpital, Shanghai JiaoTong University School of Medicine

🇨🇳

Shanghai, China

Peking University First Hospital

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath